$22.04
-0.24-1.08%
al cierre: Aug 18, 5:00 PM EST
$22.00
-0.04-0.18%
After hour: 9:02 AM EST
Sutro Biopharma Inc
STRONASDAQ
Ganancias: Los beneficios de Q2 2026 se publicaron el mié ago 12th, antes de la apertura del mercado
Sutro Biopharma Earnings & Forecasts
Sutro Biopharma (STRO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Sutro Biopharma Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.22 | $-3.04 | $-4.52 | $-3.70 |
| Actual | $-2.33 | $-2.94 | $-5.29 | $-6.70 |
| Surprise | -4.95% | +3.29% | -17.0% | -81.1% |
| Revenue | ||||
| Estimate | $11.1M | $7.7M | $8.6M | $8.8M |
| Actual | $9.8M | $14.5M | $11.6M | $9.7M |
| Surprise | -11.2% | +88.1% | +34.9% | +10.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.51 | $-1.94 | $-1.79 | $-1.89 |
| Revenue | ||||
| Consensus | $7.8M | $12.2M | — | — |